Board-Certified Internist and Renowned Professional Sports Team Physician, Dr. Michael S. Farber, Joins RNA Disease Diagnostics’ Advisory Board
Retrieved on:
Thursday, September 2, 2021
Antisense RNA, Gold Cup, Health, Sense (molecular biology), COVID-19 testing, San Francisco Giants, NFL, Awareness, NJ/NY Gotham FC, New York Liberty, Advisory board, COVID-19, New Jersey Devils, Organization, Assistant, POC, Concussion, Infection, Medical director, NWSL, NBA G League, AHL, Â, Deep vein thrombosis, Nicolás Benedetti, MLS, Company, NBA, Hackensack Meridian School of Medicine, Thrombosis, Brooklyn Nets, WNBA, NHL, Athlete, GLOBE, New York Red Bulls, Hackensack University Medical Center, Vaccine, Pharmaceutical industry
BALTIMORE, Sept. 02, 2021 (GLOBE NEWSWIRE) -- RNA Disease Diagnostics, Inc. (RNADD), a company developing a best-in-class molecular diagnostics platform to democratize point-of-care and home-use infectious disease detection, announced today the appointment of Michael S. Farber, M.D.
Key Points:
- BALTIMORE, Sept. 02, 2021 (GLOBE NEWSWIRE) -- RNA Disease Diagnostics, Inc. (RNADD), a company developing a best-in-class molecular diagnostics platform to democratize point-of-care and home-use infectious disease detection, announced today the appointment of Michael S. Farber, M.D.
- A board-certified internist, Dr. Farber is the Medical Director of Executive Health at Hackensack University Medical Center and Assistant Professor of Medicine at Hackensack Meridian School of Medicine.
- He is also the Founding Partner of Baker Street Health and Human Performance, a company that integrates health and well-being with optimal performance.
- I am energized by this opportunity to contribute to RNADDs Advisory Board at this pivotal time.